CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
Start Date
11/5/2018
Completion Date
5/31/2029
Summary
This is an open-label, non-randomized study. The purpose of this study is to better understand how vaccines against typhoid fever and cholera affect the normal immune system and bacteria in the intestine. Patients having standard-of-care endoscopies (colonoscopy and/or esophagogastroduodenoscopy (EGD)) will be divided into 3 groups: Group 1: Vivotif typhoid vaccination and/or Vaxchora cholera vaccination then endoscopy Group 2: Endoscopy, then Vivotif typhoid vaccination and/or Vaxchora cholera vaccination, then follow-up endoscopy Group 3: Endoscopy without vaccination. Both vaccines used in this study are licensed by the Food and Drug Administration (FDA) for travelers to developing countries. Volunteers will be asked to donate tissue, blood, saliva and stool samples for studying how the body responds to the typhoid and/or cholera vaccine.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Vivotif Typhoid Oral Vaccine
Vaxchora
Conditions
Locations
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Baltimore, Maryland 21201
United States